James M. Gower
2010
In 2010, James M. Gower earned a total compensation of $2.5M as Chief Executive Officer, Chairman of the Board and Director at Rigel Pharmaceuticals, a 26% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $302,400 |
|---|---|
| Option Awards | $1,583,802 |
| Salary | $630,000 |
| Other | $3,564 |
| Total | $2,519,766 |
Gower received $1.6M in option awards, accounting for 63% of the total pay in 2010.
Gower also received $302.4K in non-equity incentive plan, $630K in salary and $3.6K in other compensation.
Rankings
In 2010, James M. Gower's compensation ranked 2,410th out of 10,439 executives tracked by ExecPay. In other words, Gower earned more than 76.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,410 out of 10,439 | 77th |
Division Manufacturing | 830 out of 3,838 | 78th |
Major group Chemicals And Allied Products | 168 out of 921 | 82nd |
Industry group Drugs | 87 out of 680 | 87th |
Industry Pharmaceutical Preparations | 69 out of 481 | 86th |
Source: SEC filing on April 3, 2013.
Gower's colleagues
We found four more compensation records of executives who worked with James M. Gower at Rigel Pharmaceuticals in 2010.
2010
Raul Rodriguez
Rigel Pharmaceuticals
Chief Operating Officer
2010
Donald Payan
Rigel Pharmaceuticals
Executive Vice President, President of Discovery and Research
2010
Ryan Maynard
Rigel Pharmaceuticals
Chief Financial Officer
2010
Elliott Grossbard
Rigel Pharmaceuticals